RS

Ritesh Singh

Active Director Director DIN 08981422
DIN 08981422 First appointment Dec 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Ritesh Singh

Data last updated:

Ritesh Singh is a Director at Affix Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Affix Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (FY 2025).

DIN 08981422
Primary Designation Director
Industry Trading
First Appointment 02 Dec 2020
Oldest Company Age 11 yrs
Largest company Affix Pharmaceuticals Private Limited · ₹4.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Dec 20202015₹4.8 Lakh (FY 2025)Active

Board colleagues of Ritesh Singh

Directorship timeline

Open interactive timeline →
Affix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ritesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Singh

Ritesh Singh currently holds 1 directorship: Affix Pharmaceuticals Private Limited (Director, since 02 Dec 2020, revenue ₹4.8 Lakh (FY 2025)).

Ritesh Singh was first appointed on 02 Dec 2020 as Director at Affix Pharmaceuticals Private Limited.

The current boards of Ritesh Singh's companies include Garima Singh (Affix Pharmaceuticals Private Limited), Poonam Singh (Affix Pharmaceuticals Private Limited), Rajnish Kumar Singh (Affix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available